Glycomet Trio 1/0.3 Tablets

Glycomet Trio 1/0.3 tablets combine three powerful anti-diabetic agents — Voglibose (0.3 mg), Glimepiride (1 mg), and Metformin Hydrochloride (500 mg, sustained release).

This triple therapy works synergistically to reduce blood sugar levels by controlling glucose absorption, stimulating insulin secretion, and improving insulin sensitivity in Type 2 Diabetes Mellitus.

Manufacturer: USV Private Limited

• Triple-action control of blood glucose levels.
• Reduces intestinal glucose absorption (Voglibose).
• Stimulates insulin release (Glimepiride).
• Improves insulin sensitivity and reduces glucose production (Metformin).
• Helps maintain steady glucose levels throughout the day.

• Voglibose IP: 0.3 mg
• Glimepiride IP: 1 mg
• Metformin Hydrochloride IP (Sustained Release): 500 mg
• Colour: Erythrosine Lake
• Excipients: q.s.

As printed on pack: “Each uncoated bilayered tablet contains Voglibose 0.3 mg, Glimepiride 1 mg, Metformin Hydrochloride 500 mg (sustained release form).”

• Take as directed by your physician.
• Swallow the tablet whole with water — do not crush or chew.
• Best taken with meals to control post-meal blood sugar spikes.

Important: Do not crush or chew the tablet. Take the whole tablet with water.

• Storage: Store in a dry place below 30°C. Protect from light and moisture.
• Keep out of reach of children.
• Use only under medical supervision.

• Schedule G & H Prescription Drug: To be sold only on the prescription of a Registered Medical Practitioner.
• Consult your doctor if you have kidney, liver, or heart conditions before use.
• Regularly monitor your blood glucose levels during therapy.
• Maintain proper diet, exercise, and hydration along with medication.

Disclaimer: For educational and informational use only. Always follow your doctor’s prescription. Product details may vary as per manufacturer updates.